• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-DR 和 CD74 的表达与肾细胞癌的免疫微环境。

HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma.

机构信息

Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.

出版信息

Anticancer Res. 2021 Jun;41(6):2841-2848. doi: 10.21873/anticanres.15065.

DOI:10.21873/anticanres.15065
PMID:34083274
Abstract

BACKGROUND/AIM: Expression of human leukocyte antigen (HLA) class I and II and CD74, which functions as a chaperone of MHC class II, play essential roles in T-cell recognition. The aim of this study was to elucidate the association between the HLAs and CD74, and their correlation with the infiltrated immune cells in renal cell carcinoma (RCC).

MATERIALS AND METHODS

We retrospectively investigated the expression of HLA-A/B/C, HLA-DR, and CD74 in 38 patients with advanced RCC (T3/T4), and evaluated their correlations with CD4 and CD8-positive T-cell infiltration using immunohistochemistry.

RESULTS

The expression of HLA-A/B/C, HLA-DR, and CD74 on cancer cells was observed in 37, 20, and 31 patients, respectively. The density of CD8- and CD4-positive T cells showed a positive correlation with HLA-DR expression. The density of CD4-positive lymphocytes was significantly associated with CD74 expression.

CONCLUSION

The expression of HLA-DR, rather than CD74, on cancer cells was potentially associated with the anti-cancer immune microenvironment.

摘要

背景/目的:人类白细胞抗原(HLA)I 类和 II 类以及 CD74 的表达,CD74 作为 MHC II 类的伴侣分子,在 T 细胞识别中发挥重要作用。本研究旨在阐明 HLA 和 CD74 的相关性及其与肾细胞癌(RCC)中浸润免疫细胞的相关性。

材料和方法

我们回顾性调查了 38 例晚期 RCC(T3/T4)患者中 HLA-A/B/C、HLA-DR 和 CD74 的表达,并通过免疫组织化学评估了它们与 CD4 和 CD8 阳性 T 细胞浸润的相关性。

结果

在 37、20 和 31 例患者中分别观察到癌细胞上 HLA-A/B/C、HLA-DR 和 CD74 的表达。CD8-和 CD4 阳性 T 细胞的密度与 HLA-DR 表达呈正相关。CD4 阳性淋巴细胞的密度与 CD74 表达显著相关。

结论

癌细胞上 HLA-DR 的表达而非 CD74 的表达可能与抗肿瘤免疫微环境相关。

相似文献

1
HLA-DR and CD74 Expression and the Immune Microenvironment in Renal Cell Carcinoma.HLA-DR 和 CD74 的表达与肾细胞癌的免疫微环境。
Anticancer Res. 2021 Jun;41(6):2841-2848. doi: 10.21873/anticanres.15065.
2
MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.肾细胞癌上的MHC II类抗原相关恒定链可能有助于宿主的抗肿瘤免疫反应。
Cancer Lett. 1997 May 1;115(1):121-7. doi: 10.1016/s0304-3835(97)04754-x.
3
HLA class I and II antigens expression in patients with renal cell carcinoma.肾细胞癌患者中HLA I类和II类抗原的表达
Saudi J Kidney Dis Transpl. 2009 Jan;20(1):97-101.
4
MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.肾细胞癌上的MHC II类抗原相关恒定链可能有助于宿主的抗肿瘤免疫反应。
Cancer Lett. 1996 Dec 3;109(1-2):15-21. doi: 10.1016/s0304-3835(96)04395-9.
5
Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.肾细胞癌中HLA-II类抗原和肿瘤浸润单核细胞的免疫组织化学分析:与临床和组织病理学数据的相关性
Neoplasma. 1999;46(3):173-8.
6
[Expression of HLA class II antigen-associated invariant chain on renal cell cancer].[肾细胞癌中HLA II类抗原相关恒定链的表达]
Nihon Hinyokika Gakkai Zasshi. 1993 Jun;84(6):1036-40. doi: 10.5980/jpnjurol1989.84.1036.
7
Differences in the frequencies of HLA-class I and II alleles between German patients with renal cell carcinoma and healthy controls.德国肾细胞癌患者与健康对照者之间HLA-I类和II类等位基因频率的差异。
Cancer Immunol Immunother. 2017 May;66(5):565-571. doi: 10.1007/s00262-017-1957-3. Epub 2017 Feb 9.
8
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.人肾细胞癌中新鲜(未培养)肿瘤浸润性T淋巴细胞的表型、细胞因子产生及细胞溶解能力
Clin Exp Immunol. 1997 Sep;109(3):501-9. doi: 10.1046/j.1365-2249.1997.4771375.x.
9
[Major histocompatibility complex class II antigens on renal cell cancer--immunohistochemical study and effect on their expression by interferon].[肾细胞癌上的主要组织相容性复合体II类抗原——免疫组织化学研究及其受干扰素对其表达的影响]
Nihon Hinyokika Gakkai Zasshi. 1990 Jul;81(7):1079-86. doi: 10.5980/jpnjurol1989.81.1079.
10
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.原发性肾细胞癌中意外大量存在的人类白细胞抗原II类呈递肽
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4163-70. doi: 10.1158/1078-0432.CCR-05-2470.

引用本文的文献

1
Spatial profiling reveals unique immune microenvironment in premenopausal triple-negative breast cancer associated with therapy response.空间分析揭示了绝经前三阴性乳腺癌中与治疗反应相关的独特免疫微环境。
J Transl Med. 2025 Jul 10;23(1):761. doi: 10.1186/s12967-025-06786-8.
2
Lifting the curse from high-dimensional data: automated projection pursuit clustering for a variety of biological data modalities.解除高维数据的诅咒:针对多种生物数据模式的自动投影寻踪聚类
Gigascience. 2025 Jan 6;14. doi: 10.1093/gigascience/giaf052.
3
Immunotherapy for Renal Cell Carcinoma-What More is to Come?
肾细胞癌的免疫疗法——未来还有什么新进展?
Target Oncol. 2025 Apr 10. doi: 10.1007/s11523-025-01143-7.
4
Development of endosome-related gene signature for the prediction of prognosis and therapeutic response in breast cancer.用于预测乳腺癌预后和治疗反应的内体相关基因特征的开发
Medicine (Baltimore). 2025 Jan 10;104(2):e41230. doi: 10.1097/MD.0000000000041230.
5
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.接受三联疗法治疗的食管癌患者的预后免疫标志物。
Cancer Immunol Immunother. 2025 Jan 3;74(2):57. doi: 10.1007/s00262-024-03891-3.
6
Potential protumor function of CD74 in clear cell renal cell carcinoma.CD74 在肾透明细胞癌中的潜在促肿瘤作用。
Hum Cell. 2024 Sep;37(5):1535-1543. doi: 10.1007/s13577-024-01110-w. Epub 2024 Jul 30.
7
Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.改变的 NCR3 剪接变异可能导致肾细胞癌患者的 NK 细胞功能缺陷。
In Vivo. 2024 Jan-Feb;38(1):174-183. doi: 10.21873/invivo.13423.
8
A Case Report of Aggressive Fumarate Hydrase-deficient Renal Cell Carcinoma With Loss of HLA Antigens.一例伴有HLA抗原缺失的侵袭性富马酸水合酶缺乏型肾细胞癌病例报告
Cancer Diagn Progn. 2023 Jul 3;3(4):522-527. doi: 10.21873/cdp.10249. eCollection 2023 Jul-Aug.